文献速递关节外科

重新评估美国全关节置换术手术量:考虑超低量手术医生

Reassessing Total Joint Arthroplasty Case Volumes in the United States: Accounting for Ultralow-Volume Surgeons.
PubMed 文献 · J Arthroplasty · 2026-06-27

该研究利用2016至2023年全国数据库分析初次全膝和全髋关节置换术的手术医生年手术量趋势,发现超低量医生(年手术量<10例)占比从57.0%升至60.0%但仅覆盖3.8%病例。排除超低量医生后,标准量医生平均年手术量从79.1例增至90.7例,中位数从44例增至53例,而典型患者所接受手术医生的平均年手术量从188.7例增至192.8例。

要点

  • 超低量医生占比高但病例少,导致总体平均手术量被低估。
  • 排除超低量医生后,标准量医生平均年手术量从79.1增至90.7例。

核心结论

  • 年均手术量被超低量医生拉低,掩盖了标准关节置换医生手术量的增长。
  • 典型全关节置换患者由高量医生治疗,且该医生年手术量从2016至2023年有所增加。

研究设计与样本

  • 基于全国数据库的回顾性描述性研究,纳入2016至2023年所有初次全膝和全髋关节置换患者。
  • 手术医生按年手术量分为标准量(≥10例/年)和超低量(<10例/年),比较排除前后趋势。

主要发现

  • 2016至2023年,总体平均手术量从35.5例增至37.7例,中位数从6例降至4例。
  • 超低量医生占比从57.0%升至60.0%,但仅占全部病例的4.1%(2016)和3.8%(2023)。
  • 标准量医生覆盖95.9%(2016)和96.2%(2023)的病例;其平均手术量从79.1例增至90.7例,中位数从44例增至53例。
  • 按患者平均,典型患者手术医生的年手术量从188.7例增至192.8例。

临床怎么用

  • 解读关节置换手术量统计时需区分超低量医生,避免低估标准量医生的实际负荷。
  • 患者实际接受的手术医生多为高量医生,其手术量呈增长趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reported average total joint arthroplasty (TJA) volumes among orthopaedic surgeons in the United States range from 22 to 65 cases per year. However, this figure is influenced by a large cohort of ultralow-volume surgeons who perform fewer than 10 TJAs annually, representing a relatively small number of patients. This study reassessed surgeon volume trends by taking ultralow-volume surgeons into account while also quantifying the average caseload of a typical TJA patient's surgeon. METHODS: A national database was used to identify all patients who underwent primary total knee and hip arthroplasty from 2016 to 2023. Surgeon volume was defined as the number of TJAs performed in a calendar year. Surgeons were categorized as standard-volume (≥ 10 cases/year) or ultralow-volume (less than 10 cases/year). Descriptive statistics were used to characterize trends before and after excluding ultralow-volume surgeons. The average caseload of a typical TJA patient's surgeon was calculated by averaging surgeon volume on a patient-by-patient basis. RESULTS: Between 2016 and 2023, mean case volume increased from 35.5 to 37.7 while the median decreased from six to four. The percentage of ultralow-volume surgeons increased from 57.0% of all surgeons in 2016 to 60.0% in 2023, accounting for only 4.1% of all cases in 2016 and 3.8% in 2023. Standard-volume surgeons accounted for 95.9% of all cases in 2016 and 96.2% in 2023. After including only standard-volume surgeons, the mean number of cases per year increased from 79.1 to 90.7, and the median increased from 44 to 53. The average patient undergoing TJA was treated by a surgeon whose annual caseload increased from 188.7 to 192.8. CONCLUSIONS: Annual case volume averages are skewed by ultralow-volume surgeons, obscuring an increase in the number of cases performed by standard joint arthroplasty surgeons. The typical TJA patient is treated by a high-volume surgeon whose caseload has increased from 2016 to 2023.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Culler MW, Iyer A, Lim MA, et al. Reassessing Total Joint Arthroplasty Case Volumes in the United States: Accounting for Ultralow-Volume Surgeons. J Arthroplasty. 2026. PMID: 42364857. doi:10.1016/j.arth.2026.06.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。